Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|3|1|35-43

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.3, Iss.1, 2005-01, pp. : 35-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 3, 2007-09 ,pp. : 177-182

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of glycine transporter-1 inhibitors

By Sur Cyrille   Kinney Gene G  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 515-521

Informa Healthcare

Access to resources Recommend Favorite

Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1311-1320

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 29, 2016-12 ,pp. : 3404-3437

Bentham Science Publishers

Access to resources Recommend Favorite